2022 Meeting Accreditation


Cutting Edge of Transplantation 

April 5-8th, 2022

Target Audience

The educational design of this activity addresses the needs of healthcare professionals (physicians, surgeons, pharmacists, nurses, and others) and researchers working in the field of transplantation.

Educational Objectives

The following overarching objectives and more specific goals have been identified for this meeting. Having participated in this meeting, attendees will be able to:

  • Review how key stakeholders in transplantation define success.
  • Identify innovations in transplant medicine during and since the pandemic that have worked and use this knowledge to strategize future interventions.
  • Discuss advances in mitigating infections and antibody mediated Injury – The Yin and the Yang of transplant medicine.

Statement of Need/Program Overview

CEoT 2022 will be an exciting exploration of primary stakeholders in organ transplantation coming together to define ideal metrics to drive equity and quality in transplant access and outcomes and discuss the key challenges that the transplant field must overcome to develop and implement these quality metrics in clinical practice.

The stage will be set by looking at current definitions of success from all key stakeholders - federal, insurers, patients, care providers and understanding the implications of having different stakeholders whose perspectives on success do not always align. The program will then delve into potential alternatives definitions of success at the societal and systems levels as well as for patients and caregivers. Tying in the themes from the ASHI meeting that CEOT 2022 immediately follows, each organ and the infectious disease group with specialized tracks will delve into the Yin and Yang of infection and rejection on the spectrum of immunosuppression. The overarching goal is to systematically examine and refine definitions of success for all stakeholders in transplantation to inform and reframe future conversations in organ transplantation.

Continuing Education Credit

This activity is jointly provided by Global Education Group and American Society of Transplantation.



How to Claim Credit

Following the meeting, all participants will receive a link to an online evaluation form. After completing this evaluation, participants may claim a certificate noting the appropriate amount of credit or request a general certificate of attendance.

For pharmacist learners, partial credit may not be awarded, so sessions must be attended in their entirety to claim credit.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Society of Transplantation. Global is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this live activity for 18 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Questions about Accreditation

For information about the accreditation of this program, please contact Global at 303-395-1782 or CME@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities